{{Rsnum
|rsid=651164
|Gene=SLC22A1
|Chromosome=6
|position=160160342
|Orientation=plus
|GMAF=0.3682
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.6 | 47.8 | 41.6
| HCB | 27.0 | 56.9 | 16.1
| JPT | 38.1 | 37.2 | 24.8
| YRI | 4.1 | 40.1 | 55.8
| ASW | 1.8 | 46.4 | 51.8
| CHB | 27.0 | 56.9 | 16.1
| CHD | 31.2 | 46.8 | 22.0
| GIH | 17.2 | 50.5 | 32.3
| LWK | 4.5 | 35.5 | 60.0
| MEX | 8.6 | 50.0 | 41.4
| MKK | 7.1 | 35.1 | 57.8
| TSI | 9.8 | 52.0 | 38.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19767753
|Trait=Prostate cancer
|Title=Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
|RiskAllele=A
|Pval=2E-9
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PMID Auto GWAS
|PMID=21743057
|Trait=None
|Title=Genome-wide association study identifies new prostate cancer susceptibility loci.
|RiskAllele=G
|Pval=2E-10
|OR=1.1500
|ORtxt=[1.10-1.20]
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs651164
|overall_frequency_n=76
|overall_frequency_d=128
|overall_frequency=0.59375
|n_genomes=45
|n_genomes_annotated=0
|n_haplomes=67
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}